-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-section-6-table-12.pdf
April 17, 2019 - CHIIPRA 194: Section 6, Table 12
Table 12: ICD-9-CM Codes to Identify Signs and Symptoms of Increased Intracranial Pressure or Herniation
Diagnosis Category
Diagnosis Detail
ICD-9-CM
Code
Visual disturbances Diplopia 368.2
Other disorders of eyelids Ptosis 374.3
Disorders of the optic nerve and visual
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
March 01, 2015 - Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents
Measures: Safe and Judicious Antipsychotic
Use in Children and Adolescents
Measure Developer: National Collaborative for Innovation in Quality Measurement
As part of the Pediatric Quality Measures Program (PQMP), the Agency for Healthcare R…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-15-presenting-data.pdf
September 01, 2015 - Module 15: Preparing and Presenting Performance Data
Primary Care
Practice Facilitation
Curriculum
Module 15: Preparing and Presenting Performance Data
Agency for Healthcare Research and Quality
Advancing Excellence in Health Care www.ahrq.gov
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-14-collecting-performance-data.pdf
September 01, 2015 - Collecting Performance Data Using Chart Audits and Electronic Data Extraction
Primary Care
Practice Facilitation
Curriculum
Module 14: Collecting Performance Data Using
Chart Audits and Electronic Data Extraction
Agency for Healthcare Research and Quality
Advancing Excellence in Health Care ww…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/topics/managing-interruptions-improve-diagnostic-decisionmaking.pdf
December 29, 2022 - Managing Interruptions to Improve Diagnostic Decision-Making: Strategies and Recommended Research Agenda
Managing Interruptions to Improve Diagnostic
Decision-Making: Strategies and Recommended Research
Agenda
Jennifer F. Sloane, PhD1,2 , Chris Donkin, PhD2,3, Ben R. Newell, PhD2,
Hardeep Singh, MD MPH1, and Ashl…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-4.pdf
January 01, 2011 - Accurate ADHD Diagnosis, Measure 1, Section 5, Attachment 4
SNAC Submission Form Measure 1: Accurate ADHD Diagnosis
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Devel…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-4.pdf
January 01, 2011 - ADHD Guidelines Review
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 4: ADHD Guidelines Review
Aspect of Care Developer Guideline Recommendations …
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
January 01, 2009 - Section 5: Evidence, Attachment 1: AAP Guideline Evidence
SNAC Submission Form ADHD Measure 2: Behavior Therapy
Section 5: Evidence
Attachment 1: AAP Guideline Evidence
Excerpt from the 2011 AAP ADHD Guideline: Preschool-aged Children
Attention-deficit/hyperactivity disorder (ADHD) is the most common neuro…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
February 02, 2012 - ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment
of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Subcommittee on Attention-Deficit/Hy…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
February 02, 2012 - DOI: 10.1542/peds.2011-2654
; originally published online October 16, 2011; 2011;128;1007Pediatrics
Quality Improvement and Management
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on
of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
ADHD: Clinical Practice Guideli…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-089-fullreport.pdf
January 30, 2017 - Behavior Therapy as First-Line Treatment for Preschool-Aged Children With ADHD
Behavior Therapy as First-Line Treatment
for Preschool-Aged Children with ADHD
Section 1. Basic Measure Information
1.A. Measure Name
Behavior Therapy as First-Line Treatment for Preschool-Aged Children
1.B. Measure Number
0089
1…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-195-section-2.pdf
January 01, 2016 - Overuse of Imaging
Overuse of Imaging
Overuse of Imaging for the Evaluation of Children with Post-Traumatic Headache
Description
The percentage of children, ages 2 through 17 years old, with post-traumatic headache who were
evaluated in the emergency depa…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Depression Screening and Follow-up for Adolescents and Adults
1
Depression Screening and Follow-up for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Screening and Follow-up for Adolescents and Adults (Health Plan)
1.B. Measure Number
0246
1.C. Measure Description
P…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-2-attach-1.pdf
February 01, 2012 - Attention Deficit Hyperactivity Disorder Performance Measurement Set
Attention Deficit Hyperactivity Disorder
Performance Measurement Set
Supported by AHRQ/CHIPRA-PQMP
Proposed by the ADHD Expert Work Group (listed in Appendix A)
In collaboration with the Pediatric Meas…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-245-fullreport.pdf
December 01, 2019 - Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults: Report
Utilization of the PHQ-9 to Monitor Depression
Symptoms for Adolescents and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults
…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-244-fullreport.pdf
December 01, 2019 - Depression Remission or Response for Adolescents and Adults: Report
1
Depression Remission or Response for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Remission or Response for Adolescents and Adults
1.B. Measure Number
0244
1.C. Measure Description
Pleas…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallprevention-training/module3/module3_tools.docx
January 01, 2012 - Fall Prevention Toolkit
Fall Prevention Toolkit
Module 3 Tools
Tool 3A: Inpatient Falls Clinical Pathway
Tool 3B: Scheduled Rounding Protocol
Tool 3C: Environmental Safety at the Bedside
Tool 3D: Environmental Safety Hazard Report
Tool 3G: Stratify Fall Scale
Tool 3H: Morse Fall Scale to use for the Case Study activit…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-247-fullreport.pdf
December 01, 2019 - Adolescent Depression Remission/Response
1
Adolescent Depression Remission/Response
Section 1. Basic Measure Information
1.A. Measure Name
Adolescent Depression Remission/Response (Provider)
1.B. Measure Number
0247
1.C. Measure Description
Please provide a non-technical description of the measure that conv…